Cancer Among Arab Americans in the Metropolitan Detroit Area by Schwartz, Kendra L. et al.
Wayne State University
DigitalCommons@WayneState
FMPHS Faculty Publications Department of Family Medicine and Public HealthSciences
1-1-2004
Cancer Among Arab Americans in the
Metropolitan Detroit Area
Kendra L. Schwartz
Wayne State University, kensch@med.wayne.edu
Anahid Kulwicki
Oakland University
Linda K. Weiss
Wayne State University
Haifa Fakhouri
Arab-American and Chaldean Council
Wael Sakr
Wayne State University
See next page for additional authors
This Article is brought to you for free and open access by the Department of Family Medicine and Public Health Sciences at
DigitalCommons@WayneState. It has been accepted for inclusion in FMPHS Faculty Publications by an authorized administrator of
DigitalCommons@WayneState.
Recommended Citation
Schwartz KL, Kulwicki A, Weiss LK, Fakhouri H, Sakr W, Kau G, Severson RK. Cancer among Arab Americans in the metropolitan
Detroit area. Ethn Dis. 2004;14(Winter): 141-146.
Available at: http://digitalcommons.wayne.edu/fmhs_pubs/1
Authors
Kendra L. Schwartz, Anahid Kulwicki, Linda K. Weiss, Haifa Fakhouri, Wael Sakr, Gregory Kau, and Richard
K. Severson
This article is available at DigitalCommons@WayneState: http://digitalcommons.wayne.edu/fmhs_pubs/1
CANCER AMONG ARAB AMERICANS IN THE METROPOLITAN DETROIT AREA 
Detroit is home to one of thp largest popula-
tions of Ar,\I,';mcricans outside' of the Middle 
Last, yet litLie is known about the Cdncer dis-
tribution in this ethnic group. The authors of 
this study created an Arab/Chaldean surnamc 
list and matched it with the Detroit SEER Reg-
istry to identify cancer cases of probahle Arabic 
descent. We then determined proport ional in-
cidence ratius (PIR) for specific cancer sites 
among metropolitan Detroit Arab Americans 
as compared to non-Arab Whites, and con-
trasted the results with Middle Eastern data. 
Arab/Chalded n men had greater proportions of 
!eukemia (2l)'}oi, multiple mYl·l()ma (46%), liver 
(64%), kidney (33%), and urinary bladder 
1.26%) cancers. Arah/Chaldean women had 
greater proportions of leukemia (23%), thyroid 
(57?o), and brain (35%) cancers as compared 
with non-!\r,',b White men ,~1I1d women. The 
cancers with significantly increased PIRs in the 
Detroit Arab/Chaldean population also are fre-
quently diagnosed in Middle Eastern countries. 
(Ethn Dis. 2004;14:141-146) 
Key Words: Cancer, Arab';rnerican, Epide-
miology, Ethnicily 
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INTRODUCTION 
Arab Americans constitute one of 
the fastest growing immigrant groups in 
American metropolitan areas, '.' yet little 
is known regarding cancer incidence 
and mortality in this population. Stud-
ies of migrant Middle Easterners have 
been performed in Australia,3 where 
higher rates of liver and bladder cancers 
were reported in men, stomach and gall-
bladder cancers in women, and thyroid 
cancers in both sexes. Migrant studies 
are difficult to perform in this country 
because denominator data are not avail-
able from the US Census Bureau. Per-
sons of Arab descent do not have a sep-
arate racial! ethnic classification; rather, 
they are grouped with '\X1hite' on US 
Census forms. 
At least 250,000 Arab-Americans 
and Chaldeans (Iraqi Christians) are es-
timated to live within metropolitan De-
troit (Macomb, Oakland, and Wayne 
counties), representing one of the largest 
concentrations of immigrant Arabs in 
the United States.' The US Census 
2000 estimates the number of Muslim-
Origin persons in metropolitan Detroit 
at 124,585, representing 2. So;.) of the 
total population,4 Undercounting, his-
torically a problem among minority 
populations,5 may account for the dis-
crepant estimates. This area is also home 
to the Metropolitan Detroit Cancer Sur-
veillance System (MDCSS), a founding 
member of the National Cancer Insti-
tute's Surveillance, Epidemiology, and 
End Results (SEER) Program and a rich 
resource of cancer incidence informa-
tion, Unfortunately, the SEER registry, 
which is dependent upon medical chart 
review for demographic information, 
lacks complete data on Arab descent. 
Therefore, cancer incidence patterns are 
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poorly defined among this growing eth-
nic group in metropolitan Detroit. 
In this study, we developed an Arahl 
Chaldean surname index to identify 
cancer cases of probable Arab/Chaldean 
descent in the M DCSS and to dcter-
mine proportional incidence ratios 
(PIR) for specific cancer sites among 
metropolitan Detroit Arab/Chaldeans as 
compared to non-Arab Whites. These 
results were also compared with cancer 
data available from Middle Eastern and 
North African countries. 
METHODS 
Determining the proportional inci-
dence of specific cancer sites for met-
ropolitan Detroit Arab/Chaldeans was a 
3-step process. The first step was the 
creation of an Arab/Chaldean surname 
list. The second step involved matching 
this list with the MDCSS Registry to 
identify cases of probable Arab/Chalde-
an descent. For some names, it was also 
necessary to supplement the surname 
using first names drawn fi'om a second 
list created by the research team. The 
final step was to determine proportional 
incidence ratios. The study was re-
viewed and approved by the Wayne 
State University Institutional Review 
Board. 
Collection of Arab/Chaldean 
Surnames 
Arab/Chaldean surnames were de-
rived from the following sources: 
Michigan Department of Community 
Health birth and death records, 
which list birthplace of the decedent 
or ancestry of the infant. The coun-
tries identified as Middle Eastern/ 
North Mrican included: Algeria, Bah-
141 
ARAB-AMERICAN CANCER PATTERNS - Schwartz et at 
Studies of migrant Middle 
Easterners have been 
performed in A ustralia, 3 
where higher rates of liver 
and bladder cancers were 
reported in men, stomach 
and gallbladder cancers in 
women, and thyroid cancers 
in both sexes. 
rain, Djibouti, Egypt, Ethiopia, the 
Gaza Strip, Iraq, Jordan, Kuwait, 
Lebanon, Libya, Morocco, North Af-
rica, Oman, Palestine, Qatar, Saudi 
Arabia, Somalia, Sudan, Syria, Tuni-
sia, United Arab Emirates, Yemen, 
and the Western Sahara. 
MDCSS. Surnames from records that 
included a birthplace from the list 
above were included in the surname 
list. 
Arab/Chaldean community outreach 
groups and professional groups such 
as the Arab Community Center for 
Economic and Social Services (AC-
CESS), Arab-American and Chaldean 
Council (ACC), National Arab-
American Medical Association, the 
Chaldean Federation, and churches 
and mosques assisted us by supplying 
Arab/Chaldean surnames. 
Two Arab-speaking research assistants 
searched metropolitan Detroit tele-
phone directories for Arab and Chal-
dean surnames. 
First names were collected from the last 
2 sources named above, as well as an 
Internet listing of baby names.6 
Surnames that recurred most fre-
quently were considered as a proxy for 
the most common Arab/Chaldean sur-
names. The total number of non-unique 
surnames gathered from all sources was 
91,000, which was reduced to 14,761 
142 
unique names. The first draft was re-
viewed and edited by authors (AK and 
HF), eliminating many non-Arab/Chal-
dean names that had arisen from the 
Department of Community Health's vi-
tal statistics. A consensus was reached 
regarding those names that should be 
discarded. Surnames that could poten-
tially identify both Arab/Chaldean and 
non-Arab/Chaldean persons were kept 
as a separate file. 
Following the first review of the sur-
name list, a "soundex" match using the 
first 3 letters of the edited surname list 
was performed with the SEER database 
in order to capture additional names 
with similar beginnings and alternative 
spellings. At the same time, the consul-
tants agreed on several name endings 
that could be used to systematically de-
lete non-Arab/Chaldean surnames. Ex-
amples of such endings selected were 
-wich, -ian, -ski, and -berg. The result-
ing list, after additions and deletions, 
was again reviewed and edited by several 
of the authors (AK, HF, WS). The final 
master Arab/Chaldean surname list con-
tained 9,225 unique names. 
The first name list also underwent a 
revision and editing process by AK. The 
first name list was used to improve the 
probability of identifying Arab/Chalde-
an cases with surnames common to 
both Arab/Chaldeans and non-ArabI 
Chaldeans (eg, George, Michael, and Si-
mon). For those surnames that might 
identify non-Arab/Chaldeans (equivocal 
surnames), a match on both first and 
last name was required to be included 
in the proportional incidence analysis. 
For female cases, the maiden name 
listed in MDCSS was the first choice for 
matching. If maiden name was not pre-
sent in the case file, the usual surname 
matching criteria were applied. 
Quality Control 
Several quality control measures 
were used to ensure that the surname 
list identified as many Arab/Chaldeans 
as possible with a minimum number of 
false positives. Three different telephone 
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validation methods were used to esti-
mate the accuracy of the list, using the 
6 metropolitan Detroit directories. The 
standard procedure for each telephone 
quality control check was: 
A telephone call was placed to a resi-
dence with a telephone number for a 
given surname on the list. 
The person who answered was asked 
whether he or she had that last name; 
if not, the caller asked to speak to 
someone with that surname. 
The respondent was then asked if he or 
she considered him/herself to be of 
Arab ancestry. The caller spoke in Ar-
abic if the respondent did not under-
stand English. 
The first quality control measure 
was performed using all surnames ob-
tained from non-state sources (approxi-
mately 20,000 non-unique names). To 
approximate a 2.5% sample, a telephone 
number from a metropolitan Detroit 
telephone directory was obtained for ev-
ery 40th surname on the alpha-ordered 
list. Of the 380 households that were 
contacted, 340 respondents (89.5%) 
identified themselves as Arab/Chaldean. 
The second quality control method 
used a surname list ordered by frequen-
cy of names. Equivocal surnames were 
included. Three telephone directories 
representing areas with sparse Arabi 
Chaldean populations were the source 
for telephone numbers. Households 
with the 50 most frequent names were 
contacted. Forty-three of the 50 names 
were found in at least one of the direc-
tories, and 29 of the names were con-
tained in all 3 directories. Of the forty-
three names found at least once, 42 
(97.7%) considered themselves to be of 
Arab/Chaldean descent. 
For the third quality control step, a 
list of approximately 1 % of the sur-
names from all reportable cases, inde-
pendent of ethnicity, in the MDCSS 
was obtained. This list was checked 
against the Arab/Chaldean master sur-
name list for overlap. The 5 overlapping 
surnames on both lists were not con-
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Fig 1. Calculated Arab/Chaldean residents in Detroit compared to 1990 US Census 
information on proporation of Arabic-speaking persons in same area. 
tacted. Households with the remaining 
143 surnames were contacted, using the 
3 telephone directories that cover the 
most densely populated Arab/Chaldean 
areas. Of the 143 households contacted, 
143 (100%) identified themselves as 
A calculation was also performed to 
determine if the number of MDCSS 
cases identified by the surname match 
was reasonable. The calculation was 
made with the assumption that ArabI 
Chaldean age-specific cancer incidence 
rates are similar to those of Whites. 
White age-specific cancer incidence 
rates were used to calculate a theoretical 
age-specific Arab/Chaldean population. 
The resulting numbers closely matched 
estimates of the metropolitan Detroit 
Arab population made by another in-
dependent group. I Further verification 
of the matched MDCSS case popula-
tion, was conducted by comparing the 
theoretical population calculated, as de-
scribed above, with 1990 US Census in-
formation on the proportion of Arabic-
speaking persons using metropolitan 
Detroit census tracts? (Figure 1). The 
theoretical age-specific Arab/Chaldean 
population was similar to the 1990 age-
specific population of census tracts with 
greater than 30% of persons who speak 
Arabic at home. 
Statistical Analysis 
SAS (Statistical Analysis System)@) 
was used to calculate age-adjusted pro-
portional incidence ratios (PIR) and 
95% confidence intervals (CI). The can-
cer sites that are routinely reported by 
SEER in their annual Cancer Statistics 
Review are included here. If there were 
fewer than 10 Arab/Chaldean cases for 
a particular cancer site, a PIR was not 
calculated. Although the MDCSS con-
tains separate data for colon, rectal, and 
rectosigmoid junction cancers, the 3 
cancer sites were aggregated into a single 
category of colorectal cancer. Similarly, 
oral cavity and pharynx is an aggrega-
tion of cancers of the lip, tongue, sali-
vary gland, mouth floor, gum, naso-
pharynx, oropharynx, hypopharynx, 
and tonsil. The specific cancer sites were 
stratified by sex and age «40 years, 
40-49,50-59,60-69, and 70 years and 
older). These age-stratifications were 
used to determine the age-adjusted 
PIRs. 
Age-adjusted cancer site-specific 
PIRs were calculated by the formula be-
low.s In general, the PIR is the observed 
number of Arab/Chaldean cases divided 
by the number of Arab/Chaldean cases 
expected if the Arab/Chaldean popula-
tion had the same proportion of cancer 
as that of the non-Arab White popula-
Ethnicity &- Disease, Volume 14, Winter 2004 
tion. Proportional incidences were used 
because incidence rates are not calcula-
ble without denominator data. 
2:d 
PIR = J 
2: tj(d*/t*j) 
where dj=number of Arab/Chalde-
an site-specific cases for 
age group j 
tj=total number of ArabI 
Chaldean cases for age 
group j 
d*j=number of non-Arab 
White site-specific cases 
for age group j 
t*j=total number of non-
Arab White cases for age 
group j 
RESULTS 
The total number of matches of the 
surname list and the SEER database for 
the years 1973-2002 was 7006; 3475 
male and 3531 female. Among men and 
women combined, Arab/Chaldeans had 
63% greater than expected proportions 
of liver cancer, 44% greater thyroid, 
29% greater leukemia, 28% greater 
Hodgkin's, 26% greater brain, 25% 
greater kidney, and 24% greater urinary 
bladder cancers than non-Arab Whites 
(Table 1). Non-Arab Whites, however, 
experienced 35% more skin melanoma, 
27% more esophagus, and 20% more 
oral cavity cancers than Arab/Chalde-
ans. 
When stratified by sex, the cancer 
sites with a greater PIR for Arab/Chal-
dean men were liver (64%), multiple 
myeloma (46%), kidney (33%), leuke-
mia (29%), and urinary bladder (26%). 
Sites with a greater PIR for non-Arab 
White men were melanoma (45%), tes-
tis (36%), esophagus (36%), and oral 
cavity and pharynx (25%). 
The proportions of thyroid, brain, 
and leukemia cancers were 57%, 35%, 
and 23% greater, respectively, for ArabI 
Chaldean women than non-Arab White 
women. Skin melanoma was again 
143 
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Table 1. Age-Adjusted Proportional Incidence Ratios (PIRs) for Arab/Chaldeans in 
the Detroit metropolitan area, 1973-2002 
Cancer Site 
Male and females 
Oral cavity and pharynx 
Esophagus 
Stomach 
Colorectal 
Liver 
Gall bladder 
Pancreas 
Larynx 
Lung/bronchus 
Skin melanoma 
Urinary bladder 
Kidney 
Brain and other nervous system 
Thyroid 
Hodgkin's 
Non-Hodgkin's 
Multiple myeloma 
Leukemia 
Males 
Oral cavity and pharynx 
Esophagus 
Stomach 
Colorectal 
Liver 
Pancreas 
Larynx 
Lung/bronchus 
Melanoma 
Prostate 
Testis 
Urinary bladder 
Kidney 
Brain and other nervous system 
Thyroid 
Hodgkin's 
Non-Hodgkin's 
Multiple myeloma 
Leukemia 
Females 
Oral cavity and pharynx 
Esophagus 
Stomach 
Colorectal 
Liver 
Gall bladder 
Pancreas 
Larynx 
Lung/bronchus 
Melanoma 
Breast 
Cervix uteri 
Corpus uteri 
Ovary 
Urinary bladder 
Kidney 
Brain and other nervous system 
Thyroid 
Hodgkin's 
Non-Hodgkin's 
Multiple myeloma 
Leukemia 
144 
Number of 
Cases 
Observed 
148 
43 
151 
784 
63 
27 
154 
86 
962 
170 
407 
199 
140 
147 
81 
253 
84 
261 
99 
30 
96 
443 
45 
83 
71 
632 
83 
862 
40 
330 
141 
77 
35 
48 
135 
55 
161 
49 
13 
55 
341 
18 
18 
71 
15 
330 
87 
1086 
506 
214 
138 
77 
58 
63 
112 
33 
118 
29 
100 
Number of 
Cases 
Expected 
185.5 
59.3 
129.3 
830.6 
38.6 
21.5 
154.4 
89.1 
1017.3 
261.0 
328.5 
159.6 
111.2 
102.2 
63.4 
237.9 
68.0 
201.9 
131.7 
46.9 
86.6 
463.2 
27.4 
83.8 
77.0 
679.3 
152.2 
844.4 
62.4 
262.3 
105.8 
68.0 
29.1 
40.0 
136.6 
37.7 
125.1 
53.3 
14.3 
44.8 
368.1 
12.2 
14.2 
70.3 
15.9 
355.2 
114.1 
1044.1 
597.8 
228.0 
133.8 
77.9 
56.8 
46.7 
71.5 
26.9 
104.4 
30.2 
81.4 
PIR (95% Confidence 
Interval) 
0.80 (0.67, 0.94) 
0.73 (0.52, 0.98) 
1.17 (0.99, 1.37) 
0.94 (0.88, 1.01) 
1.63 (1.25, 2.09) 
1.25 (0.83, 1.83) 
1.00 (0.85, 1.17) 
0.97 (0.77, 1.19) 
0.95 (0.89, 1.01) 
0.65 (0.56, 0.76) 
1.24 (1.12, 1.37) 
1.25 (1.08, 1.43) 
1.26 (1.06, 1.49) 
1.44 (1.22, 1.69) 
1.28 (1.01, 1.59) 
1.06 (0.94, 1.20) 
1.24 (0.99, 1.53) 
1.29 (1.14, 1.46) 
0.75 (0.61,0.92) 
0.64 (0.43, 0.91) 
1.11 (0.90, 1.35) 
0.96 (0.87, 1.05) 
1.64 (1.20, 2.20) 
0.99 (0.79, 1.23) 
0.92 (0.72, 1.16) 
0.95 (0.86, 1.01) 
0.55 (0.43, 0.68) 
1.02 (0.95, 1.09) 
0.64 (0.46, 0.87) 
1.26 (1.13, 1.40) 
1.33 (1.12, 1.57) 
1.13 (0.89, 1.41) 
1.20 (0.84, 1.67) 
1.20 (0.89, 1.59) 
0.99 (0.83, 1.17) 
1.46 (1.10, 1.90) 
1.29 (1.10, 1.50) 
0.92 (0.68, 1.21) 
0.91 (0.48, 1.55) 
1.23 (0.92, 1.60) 
0.93 (0.83, 1.03) 
1.48 (0.87, 2.33) 
1.27 (0.75, 2.01) 
1.01 (0.79, 1.27) 
0.94 (0.53, 1.55) 
0.93 (0.83, 1.04) 
0.76 (0.61, 0.94) 
1.04 (0.98, 1.10) 
0.85 (0.77, 0.92) 
0.94 (0.82, 0.92) 
1.03 (0.87, 1.22) 
0.99 (0.78, 1.24) 
1.02 (0.78, 1.32) 
1.35 (1.04, 1.73) 
1.57 (1.29,1.88) 
1.23 (0.85, 1.72) 
1.13 (0.94, 1.35) 
0.96 (0.64, 1.38) 
1.23 (1.00, 1.49) 
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greater In non-Arab White women 
(28%), as was cervical cancer (15%) 
compared with Arab/Chaldean women. 
DISCUSSION 
This study represents an initial effort 
to describe cancer patterns among Arab 
Americans, a growing segment of the 
population that has not been well char-
acterized for health and disease status. 
An Arab/Chaidean surname database 
was developed and used to identifY 
Arab/Chaldean cancer cases in the De-
troit SEER database. Multiple methods 
of identifYing and validating Arab/Chal-
dean surnames (and first names) were 
employed to maximize the sensitivity 
and specificity of the surname database. 
In addition, our estimates of the age-
specific Arab/Chaldean population 
closely approximated the US Census 
counts of Arab-speaking households in 
the Detroit metropolitan area. 
Our results bore some similarities to 
the limited literature that was available 
from Middle Eastern countries. Data 
from only 2 Middle Eastern population-
based cancer registries are easily avail-
able. Other cancer data were utilized 
from cancer registries based in large can-
cer treatment centers, such as Cairo 
University or the American University 
of Beirut. Incidence data from these 
non-population-based sources may be a 
reflection of the treatment expertise of 
the center, rather than a true indication 
of the population's cancer rates. 
Lung cancer is common among 
male Israeli non-Jews and men in Ku-
wait, Gaza, and Lebanon.9- 11 Bladder 
cancer is reported often among men in 
Kuwait, Gaza, Lebanon, Egypt, and Is-
raeli non-Jews. 9-11 Lymphoma and leu-
kemia are frequently diagnosed in 
Egypt, Lebanon. and Gaza. IO•11 Liver 
cancer is a common digestive cancer in 
Gaza and Kuwait.IO,11 The male Detroit 
Arab-American population had in-
creased PIRs of liver, bladder, kidney, 
leukemia, and multiple myeloma. 
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Proportionately fewer cancers 
of testis, oral cavity, and 
esophagus among Arabi 
Chaldean men and fewer 
cervical cancers among 
women were noted. 
Breast cancer is among the most 
common cancer diagnoses for female Is-
raeli non-Jews and women from Ku-
wait, Lebanon, Gaza, and Egypt.9- 11 
Lymphoma is frequently diagnosed in 
Kuwait, Lebanon, Gaza, Egypt, and 
among Israeli non-Jewish women9- 11 ; 
leukemia is also common in Gaza and 
Lebanon.lo,11 Brain cancer is a leading 
cancer diagnosis for women in Gaza and 
Lebanon, 10, II while thyroid cancer is a 
malignancy common to Kuwaiti wom-
en.9 In our study, Arab-American wom-
en had proportionally more leukemia, 
brain, and thyroid cancers compared 
with non-Arab Whites. A trend among 
Arab/Chaldean women for more liver 
and gall bladder cancers was also evi-
dent. Liver cancer appears to be fairly 
common in Gaza and Kuwait,9,IO while 
the migrant study conducted in Austra-
lia noted an increase in female gallblad-
der cancer.3 
Proportionately fewer cancers of tes-
tis, oral cavity, and esophagus among 
Arab/Chaldean men and fewer cervical 
cancers among women were noted. Mel-
anoma was significantly less common 
among both Arab/Chaldean men and 
women. Similarly, these cancers, report-
ed to be significantly less common for 
Arab/Chaldean men and women, are 
also uncommon cancers in the Middle 
East. 
These similarities highlight the fact 
that migrant populations possess similar 
cancer patterns to their home country 
when first emigrating to their country 
of adoption, and eventually develop 
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most cancers at rates comparable to 
those of the native population in their 
new homeland. 12 Migrants from the 
Middle East arrived in Detroit in either 
of 2 waves. The first wave began at the 
turn of the century; the second wave be-
gan after World War II, I and continues 
to the present day. Descendants of the 
first wave of immigrants would be more 
likely to experience cancer rates com-
parable to non-Arab Whites, perhaps 
accounting for non-significant PIRs for 
lung and colon cancer, neither of which 
are among the top 5 cancer diagnoses in 
Gaza and Egypt. IO On the other hand, 
more recent immigrants may be expe-
riencing cancer patterns similar to their 
homeland, namely lymphoma and leu-
kemia, liver and bladder for men; thy-
roid and brain cancer for women. A he-
reditary predisposition for these cancers 
may also exist among Middle Eastern 
immigrants. 
Several limitations to this study de-
serve mention. The authors attempted 
to create a surname list that was as in-
clusive as possible that would identify a 
minimum number of non-Arab/Chal-
dean persons. The final list was decided 
by consensus. Three reviewers, who are 
very active in the Arab community, de-
cided on the final list. Only 89.5% of 
telephoned persons with a surname 
from the list identified themselves as 
Arab or Chaldean indicating the diffi-
culty we encountered in creating such a 
list. Many names from the Chaldean 
community such Abraham, George, and 
Simon are often found in a non-Arab 
White community. Yet, the reviewers 
felt a large proportion of the population 
might be missed if these names were 
simply removed. To minimize this ob-
stacle, we developed a first name list and 
required both a first and last name 
match with these equivocal surnames. 
Another limitation of this study was its 
omission of information on time of im-
migration to the United States; conse-
quently, we were unable to determine if 
the Arab/Chaldean cancer cases repre-
sent first or subsequent generation im-
migrants. 
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One intriguing finding from this 
study requires additional research. The 
smoking rate (39%}13 among Arab 
Americans in the Detroit metropolitan 
area is substantially greater than national 
(23%) 14 and Michigan (26%) rates. 15 
Despite this, some smoking related can-
cers were either significantly less (25% 
fewer oral cavity and pharynx, and 36% 
fewer esophageal cancers) or more (26% 
greater bladder) common among ArabI 
Chaldeans compared with non-Arab 
White men, while the lung and larynx 
proportional incidence was similar for 
the 2 groups. Oral cavity cancers are not 
common in the Middle East,9-11 except 
in Egypt where it ranks third in fre-
quency.IO Some of the increased bladder 
cancer risk could be related to the high 
rates seen in parts of the Middle East. 
As much as 50% of bladder cancer in 
Egypt and other parts of the Middle 
East is related to bilharzia (Schistosoma 
haematobium}.lo Perhaps the increased 
bladder PIR is due to first generation 
immigrants who were exposed to this 
pathogen in their home country. How-
ever, the majority of bilharzial-related 
cancers in Mrica are of squamous cell 
histology,12 while over 90% of the blad-
der cancers in our population were of 
transitional cell origin. 
This descriptive study was the first 
to determine cancer patterns in Middle 
Eastern immigrants to the United 
States. Although we made multiple ef-
forts to ensure that our surname list was 
as complete as possible, we view our re-
sults as preliminary. Remembering that 
proportional data are not necessarily an 
accurate reflection of population-based 
incidence rates is a particularly impor-
tant point; yet, it is reassuring to note 
that the patterns seen in our propor-
tional incidence study were similar to 
those identified in the migrant study of 
Middle Easterners to Australia, which 
was able to calculate incidence rates."~ 
Until US denominator data are available 
and complete ethnicity data are present 
in the medical chart, improved estimates 
will be difficult to obtain. These types 
145 
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of data are useful for hypothesis gener-
ation, as well as following trends among 
the growing Arab/Chaldean population. 
Specifically, additional migration studies 
should be done to improve our under-
standing of gene-environment interac-
tions for cancers in this unique popu-
lation. 
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